J&J | Built to matter: oncology startup strategies to stand out in a crowded market

J&J | Built to matter: oncology startup strategies to stand out in a crowded market

This Johnson & Johnson Innovation event brings together investors, pharma leaders, biotech executives and advisors to explore the strategic choices that can make oncology startups more investable, partnerable and attractive to potential acquirers.

Gain practical perspectives on the strategic decisions that can shape an oncology venture’s path forward. The programme will explore investor and buyer expectations, clinical development considerations and the factors that influence successful partnerships.

Register for the event here.

Testimonials

testimonial

ASTP's conference helped us to network with decision-makers in the technology transfer industry and provides a great platform to discuss future innovation in this sector.

Christopher Römer

Inventtory, Germany

testimonial

This course gives an in-depth understanding on managing contract portfolio, including research contracts, license agreements, and other collaboration agreements.

Ram Siddappa

Erasmus MC, Netherlands

testimonial

The event had something to offer all members of the TT community from entry level to mid-career and beyond.

John Gleeson

University of Limerick, Ireland

testimonial

This was the right decision giving me the broadest overview, confidence, tools, network and support that is fundamental to feel right in my daily decision process and to keep on learning.

Ricardo Castro

Centre for research in agricultural Genomics, Spain

testimonial

Recent studies on both sides of the Atlantic, directed by either ASTP or AUTM, demonstrate the tremendous economic and societal benefit and value technology transfer has brought us.

Koenraad Debackere

KU Leuven, Belgium